Latest News and Press Releases
Want to stay updated on the latest news?
-
NEWARK, Del, Aug. 27, 2024 (GLOBE NEWSWIRE) -- As per the latest analysis, the biosimilar and biologics market value is estimated to reach USD 520.9 billion in 2024. Global sales of biosimilar and...
-
New York, June 11, 2024 (GLOBE NEWSWIRE) -- Overview: The Global Biosimilars Market size was reached USD 25.5 billion in 2023 and is further anticipated to reach USD 117.9 billion by 2033...
-
Visiongain has published a new report entitled Biosimilars and Follow-On Biologics Market Report 2024-2034: Forecasts by Product Type (Recombinant Non-Glycosylated Proteins (Human Growth Hormone,...
-
Wilmington, Delaware, United States, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global biosimilars market is estimated to flourish at a CAGR of 15.5% from 2022 to...
-
Jersey City, NJ, Nov. 29, 2023 (GLOBE NEWSWIRE) -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Non-Oncology Biologics and Biosimilars Market -...
-
WASHINGTON, Nov. 07, 2023 (GLOBE NEWSWIRE) -- The Biosimilars Market is valued at USD 35.14 Billion in 2022 and is expected to reach USD 216.32 Billion by 2030 at a CAGR of 25.50% over the forecast...
-
Wilmington, Delaware, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Allied Market Research released a report, titled, “Biosimilars Market by Type (Erythropoietin, Human growth hormone, Monoclonal antibodies,...
-
Ottawa, Aug. 17, 2023 (GLOBE NEWSWIRE) -- The global biosimilars market revenue is projected to reach around USD 76,920.96 million by 2029, a study published by Towards Healthcare a sister firm of...
-
New York, USA, May 25, 2023 (GLOBE NEWSWIRE) -- Biosimilars Market Overview: According to a Comprehensive Research Report by Market Research Future (MRFR), “Biosimilars Market Information, By...
-
Pune, Feb. 28, 2023 (GLOBE NEWSWIRE) -- According to Market.us, the global biosimilars market accounted for USD 9.5 billion in 2022 and is projected to reach USD 34.4 billion by 2032, exhibiting a...